In a retrospective study covering the past 30 years at a tertiary cancer care institution, Radkani and coauthors review 30 patients with primary breast lymphoma (stage I or II) and analyze the different treatment modalities.
This systematic review assesses how breast implant–associated anaplastic large cell lymphoma develops; describes its risk factors, diagnosis, and subsequent treatment; and aims to disseminate information about this entity to the medical field at large.
This cohort study examines the behavior and outcomes of deficient DNA mismatch repair in patients at elevated risk for malignant neoplasms, including pancreatic ductal adenocarcinoma.
This study analyzes patient and tumor characteristics to create a model that can predict survival benefits from adjuvant chemotherapy among patients with stage II or stage III gastric cancer.
You currently have no searches saved.